Cytokinetics to Participate in Annual Healthcare Conference

The biopharmaceutical company will present at the 25th Annual Needham Virtual Healthcare Conference.

Apr. 7, 2026 at 7:07am

Got story updates? Submit your updates here. ›

A ghostly, translucent X-ray image revealing the delicate internal structures of a human heart muscle, conceptually representing Cytokinetics' focus on developing new treatments for cardiac dysfunction.Cytokinetics' innovative cardiac therapies aim to address the complex inner workings of the heart muscle.South San Francisco Today

Cytokinetics, Incorporated, a specialty cardiovascular biopharmaceutical company, announced that members of its management team are scheduled to participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference on April 13, 2026. The webcast of the presentation will be available on the company's website.

Why it matters

Cytokinetics is a leading developer of potential new medicines for patients with cardiac muscle dysfunction, including its approved drug MYQORZO® for the treatment of obstructive hypertrophic cardiomyopathy. This conference appearance provides an opportunity for the company to share updates on its pipeline and engage with the healthcare investment community.

The details

The fireside chat at the Needham Virtual Healthcare Conference will take place on Monday, April 13, 2026 at 1:30 PM Eastern Time. Interested parties can access the live webcast on the Investors & Media section of the Cytokinetics website, and the replay will be available for 90 days following the event.

  • The fireside chat will take place on April 13, 2026 at 1:30 PM Eastern Time.
  • The webcast replay will be available for 90 days after the event.

The players

Cytokinetics, Incorporated

A specialty cardiovascular biopharmaceutical company that is developing potential new medicines for patients with cardiac muscle dysfunction, including its approved drug MYQORZO® for the treatment of obstructive hypertrophic cardiomyopathy.

Got photos? Submit your photos here. ›

The takeaway

Cytokinetics' participation in the prestigious Needham Virtual Healthcare Conference underscores the company's position as a leader in the development of innovative cardiac therapies. The webcast will provide investors and the healthcare community with an opportunity to learn more about Cytokinetics' pipeline and strategic priorities.